ALZHEIMER'S FUND SUPPORT RESEARCH CURE INC (EIN 821402154) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2017

Legal Domicile

Principal Officer

TATIANA SHERMAN

Phone

9782245181

Tax Period

2023-05-01 to 2024-04-30

ALZHEIMER'S FUND SUPPORT RESEARCH CURE INC, founded in 2017, is a micro nonprofit in the Philanthropy & Grantmaking sector that reported $80K in total revenue in fiscal year 2023. Revenue decreased 16% compared to the prior year. Expenses of $70K left a modest 12% surplus.

Mission

TO SUPPORT THE WORK OF NON-PROFIT ORGANIZATIONS WHOSE CHARITABLE PROGRAMS ASSIST INDIVIDUALS WITH ALZHEIMERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $74,781

Program Service Revenue $5,087

Investment Income $0

Other Revenue $0

TOTAL REVENUE $79,868

Expense Breakdown

Grants Paid $26,538

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $61,989

Other Expenses $43,634

TOTAL EXPENSES $70,172

Year-over-Year Comparison

	2023	2022	Change
Revenue	$79,868	$95,358	-0.2%
Expenses	$70,172	$87,419	-0.2%
Net Income	$9,696	$7,939	+0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BENJAMIN GOULET	SECRETARY	1.00	Officer Director	$0	$0	$0
DANIEL LEIGHTON	TREASURER	1.00	Officer Director	$0	$0	$0
TATIANA SHERMAN	PRESIDENT	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$79,868	$70,172	$84,687	$9,696
2023	$95,358	$87,419	$75,024	$7,939
2022	$111,840	$95,381	$71,522	$16,459
2021	$103,228	$87,406	$51,595	$15,822
2020	$121,104	$97,915	$36,697	$23,189
2019	$20,555	$9,322	$13,441	$11,233

ALZHEIMER'S FUND SUPPORT RESEARCH CURE INC